BBIO · Healthcare · $12.9B
After-hours $66.910.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“매출이 1억2100만 달러에서 네 분기 연속 증가해 이번 분기 2억4400만 달러까지 커졌고, 직전 분기 1억9500만 달러보다 4900만 달러”
In the company's words · 2026 2분기 earnings call